SCPH: scPharma Consensus Target

scPharmaceuticals Inc. (SCPH) is currently launching its primary cardiology product, with distribution costs temporarily exceeding profits, which fixes the indicator at 7.80. The business relies on the development of advanced wearable pumps and liquid formulations for outpatient treatment. This price chart on GURU.Markets complements data regarding the importance of strict logistics when transporting such specific subcutaneous agents.

scPharmaceuticals, Inc. (SCPH) - Analyst Consensus Forecast from 07/04/2022 to 10/18/2025

Analytical breakdowns for scPharmaceuticals Inc. (SCPH)

- price and consensus price forecast:

Market Chart scpharmaceuticals.com|SCPH - Analyst Consensus Forecast

- market capitalization information:

Market Valuation scPharma|SCPH - Total Company Value

- book value of equity indicators:

Share Book Value scPharmaceuticals|SCPH - Book Capitalization|Market Value to Book Value scpharmaceuticals.com|SCPH - Aggregate Company Assets

- issuer credit burden and liquidity indicators:

Aggregate Debt to Equity scPharmaceuticals Inc.|SCPH - Long-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital scpharmaceuticals.com|SCPH - Company Aggregate Debts|Debts to Book Capitalization scPharma|SCPH - Company Long-Term Debt|Company Short-Term Loans and Borrowings scPharmaceuticals|Quick Liquidity Indicator scpharmaceuticals.com

- earnings and valuation multiples indicators:

SCPH - Net Profit|Projected Future Earnings scPharmaceuticals Inc.|SCPH - Price to Earnings Ratio|Future Price to Earnings Multiple scpharmaceuticals.com|SCPH - Price/Earnings to Growth Ratio|Company Value to EBITDA scPharma|SCPH - Operating profit before deduction of amortization|Earnings per share for the last four quarters scPharmaceuticals|SCPH - Net earnings per share (EPS TTM)|Year-over-year earnings per one share growth for the last 12 months scpharmaceuticals.com|SCPH - Earnings growth in current year|Expected net earnings per share growth next year scPharmaceuticals Inc.

General company analysis:SCPH scPharmaceuticals, Inc.

Flagship merchandise of scPharmaceuticals

This indicator captures the trend of the average target share price, consolidating daily valuation revisions from investment banks into a single line to identify shifts in market consensus. By analyzing the weighted consensus target for the stock, an investor can assess how the production robotization and automation of cartridge filling lines at scPharmaceuticals Inc. (SCPH) are reflected in the professional analysts' revaluation of the business's fair value.

Competitors of scPharmaceuticals Inc.